HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Two novel missense mutations observed in nonketotic hyperglycinemia.

Abstract
Nonketotic hyperglycinemia, also known as glycine encephalopathy, is an autosomal recessive disorder of an inborn error of the glycine metabolism, caused by deficiency in the mitochondrial glycine cleavage enzyme. The majority of cases are caused by mutations in P-protein, one of the four components of the glycine cleavage enzyme, glycine decarboxylase. We describe a male neonate with hypotonia, hiccups, and persistent apnea, but without seizures. The patient's glycine level in cerebrospinal fluid and plasma was 328.3 nmol/mL (reference value, 2.2-14.2 nmol/mL) and 1439 nmol/mL (reference value, 232-740 nmol/mL), respectively. The cerebrospinal fluid/plasma ratio of 0.228 represented an increase (normal range, <0.04). Two novel heterozygous missense mutations (c.1130C>T (p.A377V) and c.2081_2088del (p.A694DfsX11) in exons 8 and 18) in the glycine decarboxylase gene confirmed the diagnosis of nonketotic hyperglycinemia.
AuthorsIn Ae Yoon, Na Mi Lee, Byoung Hoon Yoo, Byong Sop Lee, Han-Wook Yoo
JournalPediatric neurology (Pediatr Neurol) Vol. 46 Issue 6 Pg. 401-3 (Jun 2012) ISSN: 1873-5150 [Electronic] United States
PMID22633639 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Topics
  • Base Sequence
  • Exons (genetics)
  • Humans
  • Hyperglycinemia, Nonketotic (diagnosis, genetics)
  • Infant, Newborn
  • Male
  • Molecular Sequence Data
  • Mutation, Missense (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: